Neuroprotective gene profile in the brain of magnesium-deficient mice

Biomedicine and Pharmacotherapy

Volumn 62, Issue 4, 2008, Pages 264-272

  German Fattal, Michèle ^a,b   Lecerf, Florence ^b   Sabbagh, Fadi ^b   Maurois, Pierre ^a   Durlach, Jean ^c   Bac, Pierre ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

^c SDRM   (France)

Author keywords

Brain; CB2; Gene expression; Hypomagnesemia; Magnesium deficiency; PRL

Indexed keywords

CELL ADHESION MOLECULE; COMPLEMENTARY DNA; MAGNESIUM; MESSENGER RNA; NEUROKININ 1 RECEPTOR; NEUROTROPHIN; PROLACTIN; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY STIMULATION; CELL ACTIVATION; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; DNA MICROARRAY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION PROFILING; HYPOMAGNESEMIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; MAGNESIUM DEFICIENCY; MOUSE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BRAIN; FEMALE; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-2; MAGNESIUM; MAGNESIUM DEFICIENCY; MICE; PROLACTIN; RECEPTORS, CANNABINOID; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 43049126850     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.02.007     Document Type: Article

References (44)

1. Galan P., Preziosi P., Durlach V., Valeix P., Ribas L., Bouzid D., et al. Dietary magnesium intake in a French adult population. Magnes Res 10 (1997) 321-328
2. Schimatschek H.F., and Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 14 (2001) 283-290
3. Weglicki W.B., and Phillips T.M. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol 263 (1992) R734-R737
4. Malpuech-Brugere C., Nowacki W., Daveau M., Gueux E., Linard C., Rock E., et al. Inflammatory response following acute magnesium deficiency in the rat. Biochim Biophys Acta 1501 (2000) 91-98
5. Nasulewicz A., Zimowska W., Bayle D., Dzimira S., Madej J., Rayssiguier Y., et al. Changes in gene expression in the lungs of Mg-deficient mice are related to an inflammatory process. Magnes Res 17 (2004) 259-263
6. Sabbagh F., Lecerf F., Maurois P., Bac P., and German-Fattal M. Severe Mg-deficiency is not associated with endothelial cell activation in mouse lung. Magnes Res 18 (2005) 225-234
7. Turner J.R., and Vink R. Magnesium in the central nervous system. In: Nishizawa Y., Morii H., and Durlach J. (Eds). New perspectives in magnesium research, nutrition and health (2007), Springer, London 338-355
8. Durlach J. Aetiology and pathophysiology of central nervous hyperexcitability due to various types of magnesium deficit: magnesium deficiency and magnesium depletion. In: Kiss S.A. (Ed). Magnesium/Mg and interaction of Mg with trace elements (1998), Hungarian Chem Soc, Budapest 11-16
9. Durlach J., Bac P., Bara M., and Guiet-Bara A. Physiopathology of symptomatic and latent forms of central nervous hyperexcitability due to magnesium deficiency: a current general scheme. Magnes Res 13 (2000) 293-302
10. Bac P. [Audiogenic seizure in the mouse according to strain and sex: the effect of the magnesium ration and neuromediators]. Reprod Nutr Dev 21 (1981) 429-440
11. Bac P., Tran G., Paris M., and Binet P. Caractéristiques de la crise convulsive audiogène chez les souris rendues sensibles par la carence magnésique. CR Acad Sci Paris (Life Sciences) 316 (1993) 676-681
12. Morris M.E. Brain and CSF magnesium concentrations during magnesium deficit in animals and humans: neurological symptoms. Magnes Res 5 (1992) 303-313
13. Eskandari F., Webster J.I., and Sternberg E.M. Neural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther 5 (2003) 251-265
14. Klein J.R. The immune system as a regulator of thyroid hormone activity. Exp Biol Med (Maywood) 231 (2006) 229-236
15. Marques-Deak A., Cizza G., and Sternberg E. Brain-immune interactions and disease susceptibility. Mol Psychiatry 10 (2005) 239-250
16. Klein T.W., Newton C., Larsen K., Lu L., Perkins I., Nong L., et al. The cannabinoid system and immune modulation. J Leuk Biol 74 (2003) 486-496
17. Cabral G.A., and Marciano-Cabral F. Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J Leuk Biol 78 (2005) 1192-1197
18. Joucher F., Mazmanian G.M., and German-Fattal M. Endothelial cell early activation induced by allogeneic lymphocytes in isolated perfused mouse lung. Transplantation 74 (2002) 1461-1469
19. Yasui M., Yano I., Yase Y., and Ota K. Distribution of magnesium in central nervous system tissue, trabecular and cortical bone in rats fed with unbalanced diets of minerals. J Neurol Sci 99 (1990) 177-183
20. Weglicki W.B., Mak I.T., Kramer J.H., Dickens B.F., Cassidy M.M., Stafford R.E., et al. Role of free radicals and substance P in magnesium deficiency. Cardiovasc Res 31 (1996) 677-682
21. Sabbagh F., Lecerf F., Maurois P., Bac P., and German-Fattal M. Allogeneic activation is attenuated in a model of mouse lung perfused with magnesium-deficient blood. Transpl Immunol 16 (2006) 200-207
22. Malpuech-Brugere C., Nowacki W., Rock E., Gueux E., Mazur A., and Rayssiguier Y. Enhanced tumor necrosis factor-alpha production following endotoxin challenge in rats is an early event during magnesium deficiency. Biochim Biophys Acta 1453 (1999) 35-40
23. Nakagawa M., Oono H., and Nishio A. Enhanced production of IL-1beta and IL-6 following endotoxin challenge in rats with dietary magnesium deficiency. J Vet Med Sci 63 (2001) 467-469
24. Weglicki W.B., Phillips T.M., Freedman A.M., Cassidy M.M., and Dickens B.F. Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 110 (1992) 169-173
25. Van Orden R., Eggett D.L., and Franz K.B. Influence of graded magnesium deficiencies on white blood cell counts and lymphocyte subpopulations in rats. Magnes Res 19 (2006) 93-101
26. Kloss C.U., Kreutzberg G.W., and Raivich G. Proliferation of ramified microglia on an astrocyte monolayer: characterization of stimulatory and inhibitory cytokines. J Neurosci Res 49 (1997) 248-254
27. Atreya R., and Neurath M.F. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol 28 (2005) 187-196
28. Oberg H.H., Wesch D., Grussel S., Rose-John S., and Kabelitz D. Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25 high regulatory T cells. Int Immunol 18 (2006) 555-563
29. Suzuki S., Yamashita T., Tanaka K., Hattori H., Sawamoto K., Okano H., et al. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats. J Cereb Blood Flow Metab 25 (2005) 685-693
30. Scarpa R.C., Carraway R.E., and Cochrane D.E. Insulin-like growth factor (IGF) induced proliferation of human lung fibroblasts is enhanced by neurotensin. Peptides 26 (2005) 2201-2210
31. LeRoith D., and Roberts Jr. C.T. The insulin-like growth factor system and cancer. Cancer Lett 195 (2003) 127-137
32. Hovey R.C., Harris J., Hadsell D.L., Lee A.V., Ormandy C.J., and Vonderhaar B.K. Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Mol Endocrinol 17 (2003) 460-471
33. Krebs D.L., Metcalf D., Merson T.D., Voss A.K., Thomas T., Zhang J.G., et al. Development of hydrocephalus in mice lacking SOCS7. Proc Natl Acad Sci U S A 101 (2004) 15446-15451
34. Martens N., Uzan G., Wery M., Hooghe R., Hooghe-Peters E.L., and Gertler A. Suppressor of cytokine signaling 7 inhibits prolactin, growth hormone, and leptin signaling by interacting with STAT5 or STAT3 and attenuating their nuclear translocation. J Biol Chem 280 (2005) 13817-13823
35. Brand J.M., Frohn C., Cziupka K., Brockmann C., Kirchner H., and Luhm J. Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur Cytokine Netw 15 (2004) 99-104
36. Torner L., Toschi N., Nava G., Clapp C., and Neumann I.D. Increased hypothalamic expression of prolactin in lactation: involvement in behavioural and neuroendocrine stress responses. Eur J Neurosci 15 (2002) 1381-1389
37. Donner N., Bredewold R., Maloumby R., and Neumann I.D. Chronic intracerebral prolactin attenuates neuronal stress circuitries in virgin rats. Eur J Neurosci 25 (2007) 1804-1814
38. van de Geijn G.J., Gits J., Aarts L.H., Heijmans-Antonissen C., and Touw I.P. G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact. Blood 104 (2004) 667-674
39. Schneider A., Kruger C., Steigleder T., Weber D., Pitzer C., Laage R., et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 115 (2005) 2083-2098
40. Meuer K., Pitzer C., Teismann P., Kruger C., Goricke B., Laage R., et al. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease. J Neurochem 97 (2006) 675-686
41. Solaroglu I., Cahill J., Jadhav V., and Zhang J.H. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 37 (2006) 1123-1128
42. Gong J.P., Onaivi E.S., Ishiguro H., Liu Q.R., Tagliaferro P.A., Brusco A., et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071 (2006) 10-23
43. Molina-Holgado F., Pinteaux E., Moore J.D., Molina-Holgado E., Guaza C., Gibson R.M., et al. Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J Neurosci 23 (2003) 6470-6474
44. van der Stelt M., and Di Marzo V. Cannabinoid receptors and their role in neuroprotection. Neuromolecular Med 7 (2005) 37-50